aktuell

Synthetic blood substitute or artificial blood is a replacement for blood. It generally replicates and fulfills some functions of blood and provides an alternative to blood transfusion. The main purpose of artificial blood is transportation of oxygen and carbon dioxide across the body. Blood loss due to traumatic injuries and diseases is responsible for thousands of deaths each year. Furthermore, fresh blood can be stored for only 42 hours. The need of a substitute to overcome blood supply shortage and increased awareness and incidence of transfusion transmitted diseases led to the invention of artificial blood substitutes. In the past, several substances such as milk, saline solution, and sheep’s blood were used as blood substitutes. Experimentation over the years led to the invention of new type of blood substitute called perflurochemical in 1966. However, it had few side effects. The artificial blood or blood substitute should possess certain characteristics to be used as replacement. It should be able to transport and release oxygen when required, should be sterile, and have definite shelf life.

Increase in demand for blood transfusion in cases such as blood loss during surgeries, trauma, and anemia led to growth of synthetic blood substitutes. Increase in incidence of disease seeking medical interventions or surgeries, rise in road accidents, military wars and trauma cases, insufficient number of blood donors, and rise in blood related disorders are the major drivers of the Synthetic Blood Substitutes And Blood Products Market. Advent of stem cell therapy has created new opportunities for players in this market. However, instability and lower shelf life of artificial blood products and stringent regulatory approval process are considered major restraints of the synthetic blood substitutes and blood products market.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26012

Based on product type, the synthetic blood substitutes and blood products market has been segmented into perflurocarbon-based products (PFC), hemoglobin-based oxygen carriers, synthetic platelets, recombinant factors, and blood expanders. Commonly used PFCs are Perfluorodecalin and Perflubron. Major advantage of PFCs is easy transportation of oxygen throughout the body. However, decrease in blood platelets count is a major side effect of usage of PFC. Hemoglobin-based blood carriers are preferred over PFCs due to longer shelf life. However, hemoglobin-based blood carriers can cause anaphylactic shock when frequently used in patients.

In terms of region, the synthetic blood substitutes and blood products market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold the largest market share owing to advanced research and development in stem cell therapy.

Key players in the synthetic blood substitutes and blood products market are BioPure, Sangart, Inc., Northfield Laboratories, Dentritech, Inc., HemoBioTech, Inc., Dextro-Sang Corp., Baxter International, FluorO2 Therapeutics, and Alpha Therapeutic Corp.

Enquiry for discount on this report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=26012

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

 

Dermatoscopy is a process through which the examination of skin lesions can be determined using an instrument, i.e., dermatoscope. The instrument is used by dermatologists to distinguish benign tumors and malignant (cancerous) lesions, especially in the diagnosis of melanoma. Modern dermatoscope uses the liquid medium and polarized light in order to cancel out the skin surface reflection. The images or videos are digitally processed using a digital epiluminescence dermatoscope. 3Gen introduced the first polarized dermatoscope known as DermLite, which allows visualization of skin structures using an immersion fluid. The convenient method of detection and different optimization of images as compared to glass dermatoscope added an advantage over vascular pattern diagnosis. However, new developments in dermatoscope allow image at the cellular and vascular level, paving way for earlier diagnosis and treatment of cancer disease.

High prevalence of skin cancer disease, rise in patient awareness about skin cancer, growth in research and development initiatives, reduction of the frequency of unnecessary surgical procedures, and high cost of treatment and diagnostic imaging procedures through MRI and X-ray devices are important driving factors of the Dermatoscope Market. According to the American Academy of Dermatology 2017, the World Health Organization has estimated that more than 65,000 people worldwide are likely to die of melanoma. In 2017, 9,730 deaths due to melanoma are estimated in the U.S. According to the WHO, 2015, the number of new cases of cancer is expected to rise by about 70% over the next two decades. Growth in technologies such as USB imaging and video technology of imaging melanoma is likely to fuel the growth of the global dermatoscope market. However, introduction of biological agents for melanoma detection and new technologies such as SPECT and PET are expected to hamper the market growth.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20945

The global dermatoscope market has been segmented based on product, technology, modality, application, and geography. In terms of product, the dermatoscope market is classified into contact dermatoscope, hybrid dermatoscope, and non-contact dermatoscope. Polarized dermatoscope (non-contact dermatoscope) is a rapid growing product segment owing to increase in prevalence of skin cancer diseases globally. In terms of technology, the market is classified into LED, xenon, halogen, and ultraviolet. In terms of modality, the market of dermatoscope is classified into hand-handled, trolley mounted, and headband. According to the Skin Cancer Foundation 2017, more than 419,000 cases of skin cancer are projected to be reported in the U.S. each year, out of which are likely to be 168,000 squamous cell carcinomas, 245,000 basal cell carcinomas, and 6,200 melanomas; these are linked to indoor tanning. In terms of application, the market is classified into skin tumors, scabies, warts, fungal infections, and others. Based on geography, the market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Geographically, North America dominates the global dermatoscope market due to increase in number of melanoma cases among men owing to tanning and ultraviolet rays. Early-phase diagnosis and treatment of the disease is driving the medical biotechnology market, which in turn is expected to drive the North America dermatoscope market. Europe is the second leading market for dermatoscope as there are favorable government policies regarding health care infrastructure and awareness among population against skin cancer. The market in Asia Pacific is expected to grow at a higher rate due to rise in population, changing lifestyle, increase in awareness about skin cancer, and growth in per capita expenditure. In addition, economic growth and rise in medical tourism along with research and cancer laboratories are supporting the health care infrastructure improvement in developing countries such as India, Brazil, and China. Thus, all the above mentioned factors collectively support the growth of the dermatoscope market in Asia Pacific and Latin America.

The major players operating in the global dermatoscope market include FotoFinder Systems GmbH, Optilia Instruments AB, Dino-Lite, 3Gen, Rudolf Riester GmbH, NIDEK CO., LTD., ILLUCO Corporation Ltd., KIRCHNER & WILHELM GmbH + Co. KG, and Canfield Scientific, Inc.

Enquiry for discount on this report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=20945

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

 

Anesthesia endotracheal tube is a tube implanted in trachea to administer anesthesia, maintain the airway passage of lungs, prevent aspiration into the lungs, and allow mechanical ventilation. It also establishes the aspiration of secretions and anticipation of the pathway of extraneous material into the tracheobronchial tree. The endotracheal tube is of two types: orotracheal tube and nasotracheal tube. The orotracheal tube is rooted through the mouth, while the nasotracheal tube is rooted through the nose into the trachea. Both are used for anesthesia management.

With the advancement of health care facilities and modern technologies, surgery of vital organs such as lungs has become easy. Anesthesia endotracheal tubes make it easy for the surgeons to sedate the patient and perform the surgical procedure. Also, these tubes are accepted and used by the patients of all age groups with breathing or lung problems. This is a major factor driving the Anesthesia Endotracheal Tubes Market. Growing industrialization leading to rise in air pollution and habits such as smoking are responsible for increasing incidence of respiratory diseases. This can be considered as a factor propelling the anesthesia endotracheal tubes market. Rising incidence of other respiratory diseases, lung diseases, and breathing disorders also drives the market.

Introduction of advanced technology in the medical field, which enables easy performing of critical surgeries and usage of high-quality consumables in the field are the recent trends in the global anesthesia endotracheal tubes market. However, availability of an increased number of alternative disposable devices and upcoming better options may act as a barrier for the anesthesia endotracheal tubes market. The anesthesia endotracheal tubes market has been segregated into organized and unorganized as well as global and regional players. The unorganized local market in developing countries may give a tough competition to the global players by maintaining high quality standards at reasonable pricing. The dealers in the developed market are targeting back with product innovations.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19298

Based on the product type, the global anesthesia endotracheal tubes market can be segmented into: orotracheal tubes and nasotracheal tubes. Orotracheal tubes are implanted in the patient’s trachea through the mouth. Nasotracheal tubes are implanted in the trachea through the nose. These tubes are employed in the cases wherein the patient’s mouth needs to be operated.

Based on the end-user, the anesthesia endotracheal tubes market can be segmented into: hospitals & clinics and ambulatory surgical centers (ASCs).

High demand for home-based therapy and modernization in video laryngoscopes also drive the global anesthesia endotracheal tubes market. However, complications in the anesthesia delivery system, availability of a small number of skilled medical practitioners to perform critical surgeries with perfection, and growing preference to laryngeal masks over anesthesia endotracheal tubes are likely be major factors restraining the growth of the market during the forecast period.

Based on the geographical region, the anesthesia endotracheal tubes market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a major market for anesthesia endotracheal tubes, due to respiratory disorder-prone lifestyle of people in the region and a large number of elderly population. Asia Pacific is an expanding market due to increase in the incidence of respiratory diseases in the region.

Some players operating in the global anesthesia endotracheal tubes market are Medline Industries, Medtronic, C. R. Bard, ConvaTec, GE Healthcare, Smiths Medical, KindWell Medical, ROYAX, Fuji Systems, Teleflex, Neurovision Medical, and Intersurgical.

Enquiry for discount on this report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=19298

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

 

Positive airway pressure devices keep pressured air flowing through the airways of the throat and is one of the common treatments for sleep apnea. The patient wears a face mask which is attached with a tube and a machine that blows pressurized air through the mask into the airway to keep it open. The air acts like a balloon holding the relaxed muscles of the throat open. Positive airway pressure (PAP) is a treatment method that uses mild air pressure to keep the airways sufficiently open. PAP devices are specially used by patients that have breathing issues, such as sleep apnea. These devices are broadly categorized as continuous positive airway pressure devices (CPAP), bi-level positive airway pressure (BiPAP), and automatic positive airway pressure devices (APAP). The growing prevalence of sleep apnea and co-morbidities related to PAP have propelled the use of positive airway pressure devices. The global positive airway pressure devices is anticipated to witness a trend of devices that are compact and comfortable through 2024.

Obstructive sleep apnea (OSA) is a chronic medical condition requiring night application of therapy to efficiently limit the number of apneas and hypopneas that would occur without intervention. The gold-standard treatment for OSA is continuous positive airway pressure therapy (PAP), which offers a pneumatic splint of the soft tissue in the upper airway. PAP devices can measure and record airflow and pressure levels whenever the device is worn. They contain internal, proprietary algorithms that identify breathing disturbances and whether these disturbances are due to persistent obstructive or non-obstructive events. Generally, the average duration of CPAP use is approximately five hours per night across numerous studies. Studies indicate that greater than six hours per night results in normal levels of objectively measured and self-reported daytime sleepiness, as well as significantly improved memory and daily functioning.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16337

Variable positive airway pressure (VPAP) or bi-level positive airway pressure (BiPAP), is a newer type of machine that reduces the amount of pressure when a person breathes out. The device uses an electronic circuit to monitor the person’s breathing. Having less pressure in the moment when a person is exhaling may make it more comfortable for the person with sleep apnea. This type of machine is used for people who have other breathing problems or who can’t sleep if they have to breathe out against a stream of air.

The U.S. accounted for the largest share in Positive Airway Pressure Devices Market. This is due to the increasing healthcare awareness for sleep apnea, improving healthcare infrastructure, rising disposable incomes, increasing obesity adding to the pool of sleep apnea patients and economic growth favored by broadening insurance coverage. Center for Medicare & Medicaid Services (CMS) provides cover for sleep apnea products, including a capped rental on CPAP/BiPAP equipment and other supplies. As per the Centers for Disease Control and Prevention (CDC), 36% of the adults in the U.S. were obese in 2010, and nearly 42% will be obese by the year 2030. Furthermore, according to National Sleep Foundation, in 2012, around 40 Mn Americans were reported to suffer from chronic sleep disorder.

Geographically, North America occupies the substantially larger market share, which is followed by Europe. The high attentiveness level in this region will lead the expansion of positive airway pressure devices market significantly. However, affordability has become a restraining factor for the global market in developing regions such as, Asia Pacific and Latin America. Asia Pacific is expected to demonstrate healthy CAGR in the global positive airway devices market. Increase in disposable income, rising aging population, and growing awareness level are some of the key factors driving the Asia Pacific market. The Asian market is expected to witness entry of higher number of new players compared to those in developed regions.

Some of the market players who are competing to bring new technologically advanced products in the market are CareFusion Corporation, GE Healthcare, Philips Healthcare, ResMed, Inc., Teleflex, Inc., and others

Enquiry for discount on this report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16337

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

 

In a highly competitive pharmaceutical industry, automation can prove to be a massive operational advantage and a key differentiator for players of all sizes. The future of the healthcare industry is increasingly being defined by the advent of faster, more accurate, and easy-to-use devices that are riding high on the wave of medical automation. With a massive number of people crossing the 60-year threshold, the healthcare industry is facing a pressing need to scale up resources and brace for a spike in healthcare needs. This is where automation is expected to be the real game changer.

There are several market dynamics that are collectively creating a need for more automation in the medical industry. According to an article published in Health Affairs, there will be a shortage of 260,000 registered nurses by 2025 in the U.S. The scenario won’t be drastically different in other developed countries where the workforce is aging rapidly. With fewer humans available to carry out all of the tasks in the healthcare industry, healthcare institutions and pharmaceutical companies are focusing on automation to get redundant and repetitive tasks done. However, as has been the case with several other industries, automation is regarded as a job killer and has been opposed in several countries worldwide.

These push and pull factors will decide how this market shapes up in the coming years. This is what the report aims to assess. The report creates segments of the global Medical Automation Market based on criteria such as applications, end-users, and geography.

Global Medical Automation Market: Drivers and Restraints

Companies and medical institutions are channeling more funds into medical automation systems and software enticed by benefits such as cost containment, increased speed, greater transparency in processing, and reduction in errors. This thus lays a strong foundation for the growth of the global medical automation market. Another change that is driving the adoption of medical automation is the high degree of interest in point-of-care testing devices for pregnancy, blood glucose levels, blood pressure, and HIV.

On the flip side, the lack of widespread standardization and a heterogeneous regulatory environment will create several obstacles for companies operating in the medical automation market. Moreover, not all healthcare institutions can afford medical automation. It will be a few years before developing countries wholly embrace this trend.

The top trends that are shaping the global medical automation market are affordable automation software and systems that make everyday tasks easier. There is a massive market that hitherto remains untapped in emerging countries, where the healthcare sector is heaving under the burden of obsolete machinery and techniques. This gap could provide a window of opportunity for companies offering medical automation software and solutions.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11921

Global Medical Automation Market: Segmentation

The global market for medical automation can be segmented broadly based on the following fronts: End user, application, and geography. The key application areas of medical automation are therapeutic automation, lab automation, pharmacy automation, and medical automation. The segment of medical automation is composed of automated imaging and analysis and point of care testing market. The market for therapeutic automation can similarly be split into surgical and non-surgical automation. Each of these sub-segments can be further segmented based on the automation devices.

Likewise, the market for lab automation can be classified into liquid handling, automated storage systems, robots and informatics, and microplate readers. The market for pharmacy automation can be further split into automated dispensaries, automated pharmaceutical packaging, and automated/smart medication compounding. The key end users in the global medical automation market are: Research labs, pharmacies, hospital and diagnostic centers, and home care centers.

Using geography as a criteria, the global medical automation market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. The market for medical automation is currently the largest in North America. It is also well-established in Europe. The rising demand for medical automation solutions and software in Asian countries such as Taiwan and China will be a crucial turning point for the market.

Companies that are currently at the forefront of the global medical automation market are: Carefusion Corp, Medtronic, Inc., GE Healthcare, Intuitive Surgical Inc., Roche Holding AG, Omnicell, Inc, Siemens Healthcare, Philips Healthcare, Stryker Corporation, St. Jude Medical, Inc., and others.

Enquiry for discount on this report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=11921

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

 

The growing number of people facing difficulties in passing urine normally is one of the key reasons why the demand for urinary tract stenting has increased over the years. The increasing incidences of tumors among people in the kidney have seen a staggering rise over the years. This is anticipated to propel the demand for urinary tract stenting over the forecast period from 2016 – 2023. Some of the other factors fueling the demand for this medical product include increasing incidences of infections in the urinary area, growing prevalence of kidney stones, and kidney infections. When any of the aforementioned conditions prevail, chances of difficulty or inability to pass urine increase and this requires doctors to make use of an artificial tube called as ureteral stent, so as to restore the flow of urine in the bladder.

This condition persists among the geriatric population to a higher extent and as the world aging population is increasing by the day, The global Urinary Tract Stenting Market will witness a healthy growth in the forecast period. As urinary tract stenting has been found to be one of the most efficient technique, enabling the flow of urine, it has been one of the most widely adopted urological practice worldwide. On the other hand, stents need to be removed within three to six months from a patient’s urinary system, as it can cause stone formation if left any longer. Stone formation in a, makes it complicated for doctors to remove the stents and a patient may then need to be hospitalized. This is one of the drawbacks of urinary tract stenting, which will hamper the growth of this market.

Urine is normally carried from the kidneys to the bladder through long, narrow, muscular tubes called ureters. The passage of urine may become difficult if the ureter becomes obstructed due to conditions such as tumors, infections, kidney stone, etc. For such conditions, the physicians place an artificial tube, known as ureteral stent, intended to restore the flow of the bladder. Aging is the most common factor that leads to several types of urology diseases. The global aging population is a direct indication of the possible rise in the patients suffering with urological diseases. With the increasing conditions that obstruct the flow of urine, the use of urological stents have become the most fundamental and valuable technique in the urological practice.

Request to View Brochure of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11072

A ureteral stent is specially designed a soft tube 10-12 inches in length that is placed in the ureter for draining urine from the kidney to the urinary bladder. These stents are coiled at both the end to stay in place in the urinary system and therefore also known as JJ stent, pig-tail stent of double J stent. Normally a person can have ureteral stents for not more than 3 to 6 months. If left for longer duration, there is a possibility of stone formation which makes removal of stents difficult. If a patient is required to have stent for a longer duration, he must be admitted in the hospital for stent change. This is a serious limitation for the usage ureteral stent.

Several companies operating in the market are trying to overcome the issue of biofilm formation and mineralogical encrustation. Furthermore, there are ongoing research activities in the global urinary tract stenting market to modify the design, discovering novel stent coating and the basic composition materials of the stent. Usage of metal stents in urology is being recommended by some physicians which have not yet become a widespread practice. Some of the advancements required for the industry include anti-body coated stents, nanotube coating, radioactive stents, and absorbable magnesium metal stent. The successful trials of the technologies have a potential to drastically change the existing market dynamics in the global urinary stenting market.

Some of the key companies operating in the global urinary tract stenting market include Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical, Inc., and Medline Industries, Inc., Pnn Medical A/S, and Allium Medical Solutions Ltd.

Enquiry for discount on this report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=11072

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

 

For recruiters, good news awaits at Jobisite. Yes, this is a site meant not just for job seekers, but also for employers. Recruiters can find the right talents for their organization with the help of this site.

Now, the site offers unlimited premium job posting service for employers. Employers can grab this excellent opportunity to source the right talents for their organization. In addition, this service comes with a special promotion. Employers thinking what does premium job posting mean? It is nothing, but the service offered by JobiSite, where their jobs will appear at top results when prospective employees search for jobs.

The excellent thing about this service offered by JobiSite is that employers will get a contact person from the site to help them with finding resumes and for recruitment. Further, the site offers virtual assistance in recruitment. Employers can also upload multiple resumes from job seekers that they have got from other sources and can place them in this portal for easy reference in the future.

Employers can try this service for free for 30 days and once they are satisfied, they can start paying $19 per month for the premium service.

About JobiSite:

JobiSite is an excellent portal that brings prospective employers and job seekers at a single place. Both of them can find each other, such that they both can be on the beneficial side.

For more information, please visit https://www.jobisite.com/employeePremium.htm

###

Dr. Schannath Executive Search mit Award ausgezeichnet

Dr. Schannath nach Überreichung des Awards durch Klaus Mantel, Geschäftsführer der Experteer GmbH (Bildquelle: @ Experteer GmbH)

Frankfurt/Hannover, 22.6.2018 – Die Kapital- und Immobilienmarkt-Personalberatung Dr. Schannath Executive Search erreichte im Rahmen der Verleihung der diesjährigen „Headhunter of the Year“-Awards in der Kategorie „Candidate Experience“ den dritten Platz und wurde mit einem der begehrten Headhunter-Awards ausgezeichnet. Die Verleihung des Awards unterstreicht das herausragende Feedback betreuter Kandidaten, die insbesondere die hohe Fachkompetenz in der Zielbranche und die hervorragende Kandidatenbetreuung hervorhoben. Die „Headhunter of the Year“-Awards werden jährlich wiederkehrend durch die Experteer GmbH verliehen.

Dr. Schannath Executive Search wurde nach 2017 bereits zum zweiten Mal fĂĽr den Headhunter of the Year Award nominiert und konnte in diesem Jahr mit dem dritten Platz in der Kategorie „Candidate Experience“ ĂĽberzeugen. Das ist das Ergebnis einer umfangreichen Kandidatenbefragung im FrĂĽhjahr dieses Jahres durch die Experteer GmbH. Zu den wesentlichen Kriterien gehörten unter anderem die „Wahl des Erstkontaktes“, die „Passgenauigkeit der angebotenen Position“, die „Professionalität“ sowie das „Know-how“ der Personalberatungen.

„Mit diesem Ergebnis, auf das wir sehr stolz sind, werden wir in unserer Philosophie bestärkt, dass nur eine intensive Betreuung der Kandidaten, ein sehr eng umrissener Branchenfokus auf den Kapital- und Immobilienmarkt und eine tiefe Vernetzung im Kundensegment zu einer win-win-Situation fĂĽr Mandanten und Kandidaten fĂĽhrt“, erläutert Dr. Schannath nach Ăśberreichung des Awards. Die Awardverleihung fand am 14. Juni 2018 im Hotel Bayerischer Hof in MĂĽnchen statt.

Ăśber Dr. Schannath Executive Search:
Die Personalberatung Dr. Schannath Executive Search besitzt 15 Jahre Beratungserfahrung bei der Besetzung von Management- und Fachpositionen in den Bereichen Kapitalmärkte/Kapitalanlage, Real Estate und betriebliche Altersvorsorge/bAV. Sie betreut deutschlandweit Kapitalanlage-, Asset-Management- und Fonds-Gesellschaften aller Segmente, Immobiliengesellschaften, Intermediäre wie Verwahrstellen und bAV-Beratungsgesellschaften sowie institutionelle und semi-institutionelle Inves-toren (Banken, Versicherungen, Versorgungswerke, Pensionskassen, Family Offices, Stiftungen etc.) bei der Besetzung exponierter Positionen. Durch diese 360°-Sicht auf das Kapitalanlagesegment, hohe fachliche Kompetenz sowie hochgradige Vernetzung auf allen Ebenen besitzt die Personalberatung einen exzellenten Zugang zu den Marktteilnehmern und ein tiefes Verständnis für die Problemstellungen im Kapitalanlagesegment. Die Personalberatung ist mit Büros in Frankfurt, Hamburg und Hannover überregional vertreten.

Kontakt
Dr. Schannath Executive Search
Dr. Heinz Schannath
MesseTurm – Friedrich-Ebert-Anlage 49
60308 Frankfurt/Main
069-50956-5437
HS@schannath.com
http://www.schannath.com

Tagged with:
 

Greco Neyland Attorneys at Law

On 22. Juni 2018, in Auto News und Verkehrsnachrichten, by marketerscenterprs
0

Greco Neyland, PCis a professional team of dedicated criminal defense lawyers that are devoted to fighting criminal charges in both state and federal court. They have successfully defended criminal cases on every level of severity and have won major felony cases in the New York Supreme Court. The lawyers at Greco Neyland are some of the most experienced and knowledgeable attorneys in New York. Greco Neyland is now delighted to announce that they are one of the top choices for NYC Grand Larceny.

 

“The district attorney’s office treats grand larceny charges as a substantial and serious offense, and so should you. The first step in building a defense to these charges is contacting a tough criminal lawyer in NYC. At Greco Neyland, we not only have the knowledge and capacity to create a defense to grand larceny charges, but we also fight hard for your acquittal.”

 

The team of dedicated professionals at Greco Neyland work around the clock to ensure that their law firm provides the best criminal defense services possible. Greco Neyland maintains a commitment to communication and honesty throughout your case. Hiring a criminal defense lawyer is an important decision, you deserve a lawyer with the skills and training to properly defend your case. Every lawyer at Greco Neyland, PC provides a free and completely confidential consultation so you can feel secure in your decision.

 

“Greco Neyland, our criminal defense attorneys have worked both sides of criminal cases. We understand how prosecutors think, plan, and act– and this prior experience is a massive advantage to our current clients.”

 

If you need a criminal defense attorney with the experience and knowledge to build you a strong defense then Greco Neyland should be your top choice. To find out a little more about Greco Neyland, PCand the services they offer, visit their website www.newyorkcriminallawyer.com or give them a call at (212) 951-1300 to put your case in the right hands.

 

 
Hypnose Hamburg | Eifersucht | Dr. phil. Elmar Basse

Dr. phil. Elmar Basse | Hypnose Hamburg

Hypnose und Eifersucht | Elmar Basse

Eifersucht kann behandlungsbedürftig sein, sagt der Hypnosetherapeut und Heilpraktiker für Psychotherapie Dr. phil. Elmar Basse von der Praxis für Hypnose Hamburg, und als behandlungsbedürftige Störung nennt man sie dann auch krankhafte Eifersucht. Dabei mag es durchaus der Fall sein, so Elmar Basse, dass der betreffende eifersüchtige Mensch keine Krankheitseinsicht besitzt. Bei vielen anderen Störungen und Leiden würde man sagen können, dass sie entweder nicht behandlungsbedürftig oder nicht behandlungsfähig seien, wenn der jeweilige Mensch über keine Einsicht verfügt, dass er krank ist, beziehungsweise wenn er seinem eigenen Bekunden nach keinen Leidensdruck hat. Bei vielen, wenn nicht den meisten Krankheiten ist es nun einmal so, dass ihr Leidensdruck, den sie mit sich führen, sehr stark zur Behandlung motiviert. Der Leidensdruck kann zwar, sagt der Hypnosetherapeut Dr. phil. Elmar Basse, von einzelnen Menschen ignoriert oder verdrängt werden. Die Behandlung kann auch hinausgezögert oder ganz vermieden werden. Eine Konsequenz dessen ist dann aber meistens eine deutliche Verschlimmerung der Symptomatik, die früher oder später eine Behandlung nahezu unvermeidlich macht.
Ist es hingegen so, dass kein Leidensdruck vorhanden ist, so kann trotzdem eine Krankheit bestehen. Bleibt sie unbemerkt und unbehandelt, droht irgendwann ein Ausbruch mit so gravierenden Folgen, dass die Behandlungsaussichten oft gering sind.
Auch im psychischen Bereich verhält es sich ähnlich. Generell fĂĽhlen sich Menschen motiviert, eine Behandlung aufzusuchen, wenn sie einen Leidensdruck haben, sagt der Hypnosetherapeut Dr. phil. Elmar Basse. Bei den sogenannten Wahnstörungen, zum Beispiel dem berĂĽhmten Verfolgungswahn, ist es ja nicht so, dass der Patient in seiner subjektiven Weltsicht an dem Wahn leidet. Er nimmt ja gar keinen Wahn bei sich war, sondern glaubt sich im Recht. Wegen des Wahns als solchem wird man ihn daher laut dem Hypnosetherapeuten Dr. phil. Elmar Basse kaum „offiziell“ behandeln können. Nur erwachsen aus der Wahnstörung meist Funktionsstörungen im LebensgefĂĽge des betreffenden Menschen, die unerträglich werden können und dann eben doch zu einer Behandlung motivieren.
Nun gibt es zwar durchaus einen Eifersuchtswahn, und dieser gilt als behandlungsbedürftige psychische Störung mit Krankheitswert. Aber dieser Eifersuchtswahn ist nur die pathologische Spitze. Die meisten eifersüchtigen Menschen betrachten sich keineswegs als psychisch krank und sind es in einer engen Definition der psychischen Krankheit auch nicht. Allerdings erzeugen und erleben sie oft einen beträchtlichen Leidensdruck in ihrem privaten, sozialen Umfeld. Lebensentwürfe können daran scheitern, Gewalttaten können entstehen, gibt der Hypnosetherapeut Dr. phil. Elmar Basse zu bedenken. Das Letztere trifft zwar nur auf eine sehr geringe Zahl der Betroffenen zu, aber die psychosozialen Folgekosten sind bei vielen Betroffenen insgesamt sehr hoch und rechtfertigen es durchaus, die Eifersucht als behandlungsbedürftig einzustufen.

Macht Erfahrung nicht oft den Unterschied? Klienten profitieren von der täglichen, intensiven Arbeit, die Dr. phil. Elmar Basse mit Hypnose ausübt und die ihm eine große Erfahrung eingebracht hat.
In seiner Praxis für Hypnose Hamburg bietet der Heilpraktiker für Psychotherapie Elmar Basse seit vielen Jahren klinische Hypnose und Hypnosetherapie an. Klinische Hypnose bei Elmar Basse kann bei einer großen Bandbreite von Anliegen helfen. Dazu zählen unter anderem die Raucherentwöhnung und die Gewichtsreduktion, aber auch die Behandlung von Ängsten und Schmerzen und vieles andere mehr. Gerne können Interessenten sich auch telefonisch oder per mail melden, um anzufragen, ob ihr Anliegen mit Hypnose bei Elmar Basse behandelt werden kann. Die Terminvereinbarung kann telefonisch erfolgen. Es steht aber auch ein Online-Terminkalender im Internet bereit, über den die Terminvereinbarung direkt elektronisch erfolgen kann.

Kontakt
Dr. phil. Elmar Basse – Hypnose Hamburg | Heilpraktiker fĂĽr Psychotherapie
Elmar Basse
Colonnaden 5
20354 Hamburg
040-33313361
elmar.basse@t-online.de
http://www.elmarbasse.de

Tagged with: